SCHEMBL6173945

SCHEMBL6173945

CC1(Cc2ccncc2C(=O)N2CCCCC2)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 15/20 0.41
TACR1 P25103 1/20 0.38
NTRK1 P04629 1/20 0.34
AR P10275 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173046 0.87 CYP3A4 (0.37) AR
SCHEMBL6173157 0.86 IGF1R (0.45) IGF1RAR
SCHEMBL6173965 0.84 IGF1R (0.43) IGF1RNTRK1ARNPC1RAB9A
SCHEMBL6172562 0.82 IGF1R (0.47) IGF1RAR
SCHEMBL2938901 0.82 IGF1R (0.60) IGF1R
SCHEMBL6172954 0.82 IGF1R (0.38) IGF1RTACR1NTRK1
SCHEMBL6173545 0.81 IGF1R (0.46) IGF1RNTRK1AR
SCHEMBL6175503 0.81 IGF1R (0.48) IGF1RNTRK1AR
SCHEMBL6174069 0.81 IGF1R (0.48) IGF1RAR
SCHEMBL6174374 0.81 IGF1R (0.48) IGF1RNTRK1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed